{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:49:39Z","timestamp":1785768579093,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1016\/0278-5846(91)90051-2","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T17:29:43Z","timestamp":1039886983000},"page":"611-623","source":"Crossref","is-referenced-by-count":11,"title":["Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers"],"prefix":"10.1016","volume":"15","author":[{"given":"Bruce A.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"O'reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy L.","family":"Placatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.Alick","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Durden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/0278-5846(91)90051-2_BIB1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0022-3956(88)90077-5","article-title":"Urinary phenylacetate and response to methylphenidate","volume":"22","author":"Baxter","year":"1988","journal-title":"J. Psychiat. Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00344060","article-title":"Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls","volume":"232","author":"Beckmann","year":"1982","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/0278-5846(91)90051-2_BIB3","series-title":"Neuropsychopharmacology of the trace amines","first-page":"3","article-title":"The trace amines: Recent overview and future pointers","author":"Boulton","year":"1985"},{"key":"10.1016\/0278-5846(91)90051-2_BIB4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-1781(83)90134-8","article-title":"Trace acid levels in the plasma and MAO activity in the platelets of violent offenders","volume":"8","author":"Boulton","year":"1983","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB5","first-page":"119","article-title":"Phenylethylamine in the CNS: Effects of monoamine oxidase inhibiting drugs deuterium substitution and lesions in its role in the neuromodulation of catecholaminergic neurotransmission","volume":"29","author":"Boulton","year":"1990","journal-title":"J. Neural Transm."},{"key":"10.1016\/0278-5846(91)90051-2_BIB6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/320769a0","article-title":"PITC derivatives in amino acid analysis","volume":"320","author":"Cohen","year":"1986","journal-title":"Nature"},{"key":"10.1016\/0278-5846(91)90051-2_BIB7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9673(01)84617-3","article-title":"Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects","volume":"466","author":"Davis","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/0278-5846(91)90051-2_BIB8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1526-4610.1987.hed2707384.x","article-title":"Investigation of some biological trait markers in migraine: deuterated tyramine challenge test, monoamine oxidase, phenolsulfotransferase and plasma and urinary biogenic amine and acid metabolite levels","volume":"27","author":"Davis","year":"1987","journal-title":"Headache"},{"key":"10.1016\/0278-5846(91)90051-2_BIB9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-4347(00)80473-9","article-title":"Plasma concentrations of p- and m-hydroxyphenylacetic acid and phenylacetic acid in humans","volume":"230","author":"Davis","year":"1982","journal-title":"J. Chromatogr."},{"key":"10.1016\/0278-5846(91)90051-2_BIB10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)83278-8","article-title":"Simultaneous analysis of twelve biogenic amine metabolites in plasma cerebrospinal fluid and urine by capillary column gas chromatography-high resolution mass spectrometry with selected ion monitoring","volume":"374","author":"Davis","year":"1986","journal-title":"J. Chromatogr."},{"key":"10.1016\/0278-5846(91)90051-2_BIB11","doi-asserted-by":"crossref","DOI":"10.1016\/0278-5846(91)90025-V","article-title":"The effect of age, sex, weight and height on the plasma concentrations of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders","volume":"15","author":"Davis","year":"1991","journal-title":"Progr. Neuro-Psychopharmacol. & Biol. Psychiat."},{"key":"10.1016\/0278-5846(91)90051-2_BIB12","article-title":"Phenylacetic acid in CSF and serum in Indian schizophrenic patients","volume":"15","author":"Davis","year":"1991","journal-title":"Progr. Neuro-Psychopharmcol. & Biol. Psychiat."},{"key":"10.1016\/0278-5846(91)90051-2_BIB13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-1781(82)90042-7","article-title":"Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients","volume":"6","author":"Davis","year":"1982","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB14","author":"Davis","year":"1990","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(84)90034-9","article-title":"Phenylethylamine excretion in depression","volume":"13","author":"De Lisi","year":"1984","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1471-4159.1980.tb11267.x","article-title":"Kinetic measurements of the turnover of phenylethylamine and tryptamine in vivo in the rat brain","volume":"34","author":"Durden","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/0278-5846(91)90051-2_BIB17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-1781(89)90152-2","article-title":"CSF phenylacetic acid and hostility in paranoid schizophrenia","volume":"30","author":"Faull","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0006-3223(85)90038-1","article-title":"Multidimensional analysis of the concentrations of 17 substances in the CSF of schizophrenics and controls","volume":"20","author":"Gattaz","year":"1985","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/0278-5846(91)90051-2_BIB19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0447.1988.tb06325.x","article-title":"Urinary phenylacetic acid excretion in depressive patients","volume":"78","author":"Gonzalez-Sastre","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/0278-5846(91)90051-2_BIB20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0003-2697(85)90333-1","article-title":"A high-pressure liquid chromatographic method for plasma phenylacetic acid, a putative marker for depressive disorders","volume":"145","author":"Gusovsky","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/0278-5846(91)90051-2_BIB21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1126\/science.6438798","article-title":"Gut flora and urinary phenylacetic acid","volume":"226","author":"Hryhorczuk","year":"1984","journal-title":"Science"},{"key":"10.1016\/0278-5846(91)90051-2_BIB22","first-page":"341","article-title":"Cross-cultural study of a biochemical abnormality in paranoid schizophrenia","volume":"3","author":"Jeste","year":"1980","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0165-1781(82)90009-9","article-title":"Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patients","volume":"6","author":"Karoum","year":"1982","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB24","first-page":"165","article-title":"Phenylacetic add excretion in schizophrenia and depression: the origins of PAA in man","volume":"19","author":"Karoum","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/0278-5846(91)90051-2_BIB25","first-page":"271","article-title":"Determination of phenylacetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry","volume":"40","author":"Kawabata","year":"1986","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/0278-5846(91)90051-2_BIB26","first-page":"1","article-title":"New weight standards for men and women","author":"Metropolitan Life Insurance Company","year":"1983","journal-title":"Statistical Bulletin"},{"key":"10.1016\/0278-5846(91)90051-2_BIB27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1471-4159.1990.tb05764.x","article-title":"B-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?","volume":"55","author":"Paterson","year":"1990","journal-title":"J Neurochem."},{"key":"10.1016\/0278-5846(91)90051-2_BIB28","series-title":"Bowes and Church's Food Values of Portions Commonly Used","author":"Pennington","year":"1985"},{"key":"10.1016\/0278-5846(91)90051-2_BIB29","first-page":"51","article-title":"Evidence for the presence of m-tyramine, p-tyramine, tryptamine and phenylethylamine in the rat brain and several areas of the human brain","volume":"13","author":"Philips","year":"1978","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/0278-5846(91)90051-2_BIB30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.504988","article-title":"Phenylethylamine in paranoid chronic schizophrenia","volume":"206","author":"Potkin","year":"1979","journal-title":"Science"},{"key":"10.1016\/0278-5846(91)90051-2_BIB31","first-page":"52","article-title":"Psychostimulants and dopamine agonists in the study of adult hyperkinesis, schizophrenia and affective disorders","volume":"16","author":"Potkin","year":"1980","journal-title":"Psychopharmcol. Bull."},{"key":"10.1016\/0278-5846(91)90051-2_BIB32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-198308000-00037","article-title":"Phenylacetic acid as an indicator in bipolar affective disorders","volume":"3","author":"Sabelli","year":"1983","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/0278-5846(91)90051-2_BIB33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0009-8981(79)90261-4","article-title":"Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness","volume":"93","author":"Sandler","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/0278-5846(91)90051-2_BIB34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(78)92037-8","article-title":"Phenylethylamine overproduction in aggressive psychopaths","volume":"2","author":"Sandler","year":"1978","journal-title":"The Lancet"},{"key":"10.1016\/0278-5846(91)90051-2_BIB35","first-page":"199","article-title":"Raised cerebrospinal fluid phenyl-acetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?","volume":"2","author":"Sandler","year":"1978","journal-title":"Commun. Psychopharmacol."},{"key":"10.1016\/0278-5846(91)90051-2_BIB36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jnnp.45.4.366","article-title":"Phenyl-acetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values","volume":"45","author":"Sandler","year":"1982","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/0278-5846(91)90051-2_BIB37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/278357a0","article-title":"Deficient production of tyramine and octopamine in cases of depression","volume":"278","author":"Sandler","year":"1979","journal-title":"Nature"},{"key":"10.1016\/0278-5846(91)90051-2_BIB38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0006-3223(87)90230-7","article-title":"Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients","volume":"22","author":"Szymanski","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/0278-5846(91)90051-2_BIB39","series-title":"WHO Technical Report Series Number 522","first-page":"55","article-title":"WHO\/FAO Report: Energy and Protein Requirements","author":"WHO\/FAO","year":"1973"},{"key":"10.1016\/0278-5846(91)90051-2_BIB40","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0165-1781(87)90027-8","article-title":"Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia","volume":"21","author":"Yoshimoto","year":"1987","journal-title":"Psychiatry Res."},{"key":"10.1016\/0278-5846(91)90051-2_BIB41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0447.1983.tb00340.x","article-title":"Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients","volume":"67","author":"Yu","year":"1983","journal-title":"Acta Psychiat. Scand."},{"key":"10.1016\/0278-5846(91)90051-2_BIB42","series-title":"Neuropsychopharmacology of the Trace Amines","first-page":"329","article-title":"Further studies on platelet monoamine oxidase and phenolsulfotransferase and plasma levels of acid metabolites in aggressive and non-aggressive prisoners and children with attention deficit disorders","author":"Yu","year":"1985"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0278584691900512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0278584691900512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T17:56:15Z","timestamp":1554054975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0278584691900512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["0278584691900512"],"URL":"https:\/\/doi.org\/10.1016\/0278-5846(91)90051-2","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}